By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arena Pharmaceuticals, Inc. 

6166 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-453-7200 Fax: 858-453-7210




Lexicon Genetics Incorporated 

Merck & Co.  Cardiovascular

Company News
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce Completion Of Enrollment In BELVIQ (lorcaserin HCI) CAMELLIA-TIMI 61 Study 12/1/2015 6:47:44 AM
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce FDA Acceptance Of New Drug Application For Extended Release Formulation Of Lorcaserin 11/30/2015 6:50:11 AM
Arena (ARNA) To Present At Piper Jaffray 27th Annual Healthcare Conference 11/24/2015 7:38:43 AM
Arena (ARNA) To Host Analyst & Investor Day On December 3rd 11/19/2015 7:39:37 AM
Arena (ARNA) Reports Third Quarter 2015 Financial Results and Provides Corporate Update 11/11/2015 8:02:35 AM
Arena (ARNA) To Host Third Quarter 2015 Financial Results And Corporate Update Conference Call And Webcast On Tuesday, November 10 11/4/2015 9:55:44 AM
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce Presentation Of Lorcaserin Hcl Data At 2015 Annual Obesity Week Meeting 11/2/2015 6:43:51 AM
Arena (ARNA) Initiates A Phase 1b Clinical Trial Of APD371 10/29/2015 6:24:38 AM
Arena (ARNA) to Chop 35% of U.S. Workforce and Push Clinical Programs Forward 10/28/2015 6:01:04 AM
Arena (ARNA) Issued Additional Patent Covering BELVIQ (lorcaserin HCl) By United States Patent And Trademark Office 10/27/2015 7:41:15 AM